Synergistic effect of Ru(II)-based type II photodynamic therapy with cefotaxime on clinical isolates of ESBL-producing Klebsiella pneumoniae
Multidrug-resistant bacteria, such as ESBL producing-Klebsiella pneumoniae, have increased substantially, encouraging the development of complementary therapies such as photodynamic inactivation (PDI). PDI uses photosensitizer (PS) compounds that kill bacteria using light to produce reactive oxygen...
Main Authors: | Dafne Berenice Hormazábal, Ángeles Beatriz Reyes, Francisco Castro, Alan R. Cabrera, Paulina Dreyse, Felipe Melo-González, Susan M. Bueno, Iván A. González, Christian Erick Palavecino |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-08-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223007394 |
Similar Items
-
Effective Treatment against ESBL-Producing <i>Klebsiella pneumoniae</i> through Synergism of the Photodynamic Activity of Re (I) Compounds with Beta-Lactams
by: Iván A. González, et al.
Published: (2021-11-01) -
Effective Photodynamic Therapy with Ir(III) for Virulent Clinical Isolates of Extended-Spectrum Beta-Lactamase <i>Klebsiella pneumoniae</i>
by: Constanza Núñez, et al.
Published: (2021-04-01) -
Influences of Initial Empiric Antibiotics with Ampicillin plus Cefotaxime on the Outcomes of Neonates with Respiratory Failure: A Propensity Score Matched Analysis
by: Mei-Chen Ou-Yang, et al.
Published: (2023-02-01) -
Persistent Colonization of Ciprofloxacin-Resistant and Extended-Spectrum β-Lactamase (ESBL)-Producing Salmonella enterica Serovar Kentucky ST198 in a Patient with Inflammatory Bowel Disease
by: Jiang Y, et al.
Published: (2024-04-01) -
Well logging II : electric and acoustic logging/
by: 459028 Jorden, James R., et al.
Published: (1986)